GlassScriptPhysician profile
Gerald P Hoke
NPI 1407951593
$7,546.49
in general payments reported to CMS, 2019-2025
27 companies · $556 in 2025
The $556 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,857 · 2020: $440 · 2021: $1,218 · 2022: $1,365 · 2023: $1,400 · 2024: $710 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,591 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,591.27 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,957.92 | 2019-2025 | Titan |
| Pfizer INC. | $1,050.38 | 2019-2025 | |
| Astellas Pharma US INC | $1,003.39 | 2019-2025 | Myrbetriq, Xtandi |
| Progenics Pharmaceuticals, INC. | $851.36 | 2023-2024 | Pylarify |
| Janssen Biotech, INC. | $550.14 | 2019-2023 | Erleada |
| Myovant Sciences INC. | $432.78 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $234.33 | 2023-2025 | Gemtesa |
| Olympus America INC. | $169.86 | 2022-2025 | Itind System |
| Dentsply Ih INC. | $153.11 | 2019-2021 | |
| Calyxo, INC. | $151.80 | 2025 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $132.68 | 2021-2023 | Lynparza, Welireg, Keytruda |
| Novo Nordisk INC | $119.79 | 2023 | |
| Blue Earth Diagnostics | $117.40 | 2021-2023 | |
| Verity Pharmaceuticals INC. | $78.55 | 2021-2023 | Trelstar |
| Tolmar, INC. | $72.24 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $72.05 | 2022-2023 | |
| Neotract INC. | $71.09 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $60.51 | 2022-2023 | Lynparza |
| Antares Pharma, INC. | $50.00 | 2023 | Xyosted, Tlando |
| Amgen INC. | $48.59 | 2019 | |
| Urovant Sciences INC | $44.57 | 2022 | |
| Alnylam Pharmaceuticals INC. | $29.21 | 2021 | |
| Abc Home Medical Supply, INC. | $24.25 | 2025 | |
| Ambu INC. | $20.00 | 2021 | |
| Hollister Incorporated | $18.29 | 2022 | |
| Boston Scientific Corporation | $16.19 | 2019 | |
| Dentsply Ih Ab | $16.01 | 2023 | Lofric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Hoke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.